A review of non‐alcoholic fatty liver disease in non‐obese and lean individuals

M Ahadi, K Molooghi, N Masoudifar… - Journal of …, 2021 - Wiley Online Library
Non‐alcoholic fatty liver disease (NAFLD) is one of the most common causes of hepatic
disorders. It represents a wide range of chronic liver diseases in patients with no history of …

Mitochondrial mutations and genetic factors determining NAFLD risk

SA Dabravolski, EE Bezsonov, MS Baig… - International journal of …, 2021 - mdpi.com
NAFLD (non-alcoholic fatty liver disease) is a widespread liver disease that is often linked
with other life-threatening ailments (metabolic syndrome, insulin resistance, diabetes …

[HTML][HTML] KASL clinical practice guidelines: management of nonalcoholic fatty liver disease

SH Kang, HW Lee, JJ Yoo, Y Cho, SU Kim… - Clinical and …, 2021 - ncbi.nlm.nih.gov
The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide
as the obese and diabetic populations increase, and it has been estimated to be 20–30% in …

Genetic polymorphisms and diversity in nonalcoholic fatty liver disease (NAFLD): a mini Review

SA Sulaiman, V Dorairaj, MNH Adrus - Biomedicines, 2022 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) is a common liver disease with a wide spectrum of
liver conditions ranging from hepatic steatosis to nonalcoholic steatohepatitis (NASH) …

Innate-immunity genes in obesity

SV Mikhailova, DE Ivanoshchuk - Journal of personalized medicine, 2021 - mdpi.com
The main functions of adipose tissue are thought to be storage and mobilization of the
body's energy reserves, active and passive thermoregulation, participation in the spatial …

[HTML][HTML] Research progress, challenges and perspectives on PNPLA3 and its variants in Liver Diseases

H **ang, Z Wu, J Wang, T Wu - Journal of Cancer, 2021 - ncbi.nlm.nih.gov
The human patatin-like phospholipase domain-containing 3 gene (PNPLA3) is highly
expressed in liver and adipose tissue and encodes a transmembrane polypeptide chain …

Effect of the patatin‐like phospholipase domain containing 3 gene (PNPLA3) I148M polymorphism on the risk and severity of nonalcoholic fatty liver disease and …

J Li, W Hua, C Ji, J Rui, Y Zhao, C **e, B Shi… - Pediatric …, 2020 - Wiley Online Library
Background The effect of the patatin‐like phospholipase domain containing 3 gene
(PNPLA3) I148M polymorphism on the risk and severity of paediatric and adolescent …

[HTML][HTML] A review of the increasing prevalence of metabolic-associated fatty liver disease (MAFLD) in children and adolescents worldwide and in Mexico and the …

MM Ramírez-Mejía, LE Díaz-Orozco… - … Medical Journal of …, 2021 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) affects almost a quarter of the world's population
and is the most common cause of chronic liver disease in children and adolescents. The …

[HTML][HTML] Update on Non-Alcoholic Fatty Liver Disease-Associated Single Nucleotide Polymorphisms and Their Involvement in Liver Steatosis, Inflammation, and …

FD Astarini, N Ratnasari… - Iranian biomedical …, 2022 - ncbi.nlm.nih.gov
Genetic factors are involved in the development, progression, and severity of NAFLD.
Polymorphisms in genes regulating liver functions may increase liver susceptibility to …

[HTML][HTML] Ameliorative effects of high intensity interval training and Lactobacillus rhamnosus GG Protect against tetracycline-induced fatty liver in rats: a gene …

HM Hosseini, H Shirvani, F Aghaei, E Arabzadeh… - EXCLI …, 2022 - ncbi.nlm.nih.gov
Exercise training and probiotics have been suggested as a treatment for the prevention of
chronic liver damage such as non-alcoholic fatty liver disease (NAFLD). Lactobacillus …